Lexi Ventures
Venture capitalActively deployingSan Francisco Β· Seed Β· 1 people tracked
Investment thesis
The firm believes biology has transitioned from a science to an engineering discipline, enabling precise reading, writing, and editing of life's genetic code at unprecedented scale. Gene technology startups can address many severe and costly diseases, improve quality of life, and reduce healthcare burdens. Additionally, gene tech enables sustainable production of new materials and products through engineered plants and microbes. Lexi targets companies leveraging DNA, RNA, cellular engineering, and omics technologies to create these solutions.
Source: firm website, verified Aug 11, 2026.
Team Β· 1 people
from public directories
What they invest in
from 5 of 12 portfolio companiesBiotech Γ3Deep Tech Γ3AI & Machine Learning Γ2Medical Devices Γ2Cleantech Γ1Healthtech Γ1Marketplaces Γ1New Materials Γ1
HQs:United StatesΓ1
Investments Β· 12 tracked
founders shown can be your intro pathAlkaLi Labs develops microbial hyperaccumulators that extract critical minerals, including lithium, from industrial waste streams to supply materials needed for green energy hardware and electrification.
BiotechCleantechNew Materials
Co-investorsCyclotron Road
RNA-based antisense therapeutics for rare genetic diseases.
Developing next-generation protein sequencing platform to redefine proteomics.
Co-investorsModi Ventures
High-fidelity CRISPR tools designed for safer, rapid clinical translation.
Engineering T-cells to eradicate solid tumors without viral vectors.
lu.ma is a platform for creating event pages, inviting attendees, and selling tickets for events.
Marketplaces
Victor Pontis(Founder)inDan Liu(Founder)
Co-investorsAir Street CapitalAtelierBonfire VenturesExceptional CapitalFirst Bight VenturesIOSG Ventures+11 more
ParcelBio develops APEXm, a proprietary mRNA platform that enhances protein expression for longer-lasting therapeutic effect compared to conventional mRNA technologies.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
David Weinberg(Founder)inChris Carlson(Founder)in
BoardMorgan Cheatham(Director)in
Co-investorsY CombinatorBreyer CapitalGeneral CatalystMetaplanetNorth South VenturesRitual Capital+3 more
QUiCKR develops rapid genetic modification quantification kits for cell and gene therapy R&D programs, analyzing structural variants, edits, and genome integrity to accelerate development timelines and reduce costs.
BiotechDeep TechMedical Devices
Charles Blanluet(Founder)in
Co-investorsCivilization Ventures Management, LlcHCVC
AI simulation platform predicting clinical trial outcomes and metabolic pathways.
Bio-engineered consumer products, starting with an active probiotic skincare.
Precision genetic medicines targeting rare and neglected pediatric diseases.
Portfolio news
latest coverage across their companiesParcelBio Β· technews180.com Β· May 8, 2026
Frequently asked questions
- How many investments has Lexi Ventures made?
- Lexi Ventures has 12 tracked investments, including 1 dated in the last 24 months.
- What stage does Lexi Ventures invest at?
- Lexi Ventures invests at the Seed stage.
- What sectors does Lexi Ventures focus on?
- Lexi Ventures focuses on AgTech, Biotech, Deep Tech, Healthtech.
- Where is Lexi Ventures located?
- Lexi Ventures is headquartered in San Francisco, US.
- Who does Lexi Ventures co-invest with?
- Lexi Ventures most often shares deals with Bonfire Ventures, Civilization Ventures Management, Llc, First Bight Ventures, among 27 tracked co-investors.
Co-investors Β· 1
Pioneer Fund is a venture capital firm investing in the top Y Combinator startups.
Firms observed investing alongside Lexi Ventures, from public investor directories. Shared companies are the overlap with Lexi Ventures's recorded portfolio.
Similar investors
Refactor is a seed-stage venture firm run as a solo capitalist by Zal, backing founders building hard tech companies that address real-world problems.
SOSV is a deep tech venture capital firm that makes first-check pre-seed investments and follow-on rounds in startups focused on human and planetary health, providing lab space and hands-on support at its US locations.
Giant Ventures Global LLP is a venture capital firm that invests in technology companies. The firm focuses on founders addressing global challenges.
Overwater Ventures is an early-stage venture firm that partners with pre-seed and seed stage founders working on large-scale problems, offering hands-on support across launch strategy, go-to-market, fundraising, and marketing.
Incubate Fund is a seed-stage, sector-agnostic venture capital firm that invests as a lead investor and first believer in founders, operating across offices in five countries with strong ties to Japan.